TOPIC	LECTURER	COUNTRY
Drug Delivery and Absorption of Peptides and Proteins (Vaccines)	H. Junginger	NL
Drug Delivery Systems To The Brain	Y. Sugiyama	JP
Artificial Viruses – The Role of Membrane-Active Peptides in Intracellular Delivery	E. Wagner	DE
New Oral Formulations of Heparin	N. Ubrich	FR
Development of Novel Delivery System of Site Specific PEGylated Peptide Drugs	K. C. Lee	KR
Dual Drug Targeting Using Therapeutic Proteins as Carriers for Cell Selective Delivery	D. K. F. Meijer	NL
Nanoscale Vaccine Carriers	M. J. Alonso	ES
Gene Delivery	I. Uchegbu	GB
Non-Invasive Vaccines: New Strategies For Vaccine Development	O. Alpar	GB
Nanotechnology- Characterization of Implantable Drug Delivery Systems	A. Goepferich	DE
Epidermal Cell Culture Model for Transdermal Drug Delivery Studies	A. Urtti	FI
Modified Release Veterinary Drug Delivery - Challenges and Solutions	M. J. Rathbone	NZ
From Laboratory to Clinical Trial: Regulatory Compliance During Product Development	D. Robinson	US
Medical and Pharmaceutical Countermeasures to Chemical Warfare Agents	D. H. Moore	US
Pharmaceutical Implications of New Iodine Formulations	U. Wormser	IL
Human Absorption and Microdosing Studies To Innovate The Drug Development Process	I. Wilding	GB
Pharmacokinetic and Gammascintigraphic Studies with Site Specific Oral Formulations	P. Veski & M. Marvola	EE
Improving Pulmonary Drug Delivery By Particle Design	H. Steckel	DE
Novel Non Aqueous Formulations Emulsions and Ionic Liquids	A. T. Florence	GB
In vitro-In vivo Correlation as Guide in Modified Release Drug Development	W. Martin	DE
Risk Assessment in Drug Development	A.P. Sam	NL